0 followers
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Bruce Culleton
Revvity
4 followers
Pfizer
441 followers
ALS Therapy Development Institute
3 followers
Earlens
1 follower
Evolution Health Group, LLC
1 follower
FUJIFILM Cellular Dynamics
1 follower
Blueprint Medicines
4 followers
Mural Oncology
1 follower
Thermo Fisher Scientific
141 followers
Stryker
112 followers
Recordati Rare Diseases North America
1 follower
Discover companies